Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001178913-12-002335
Filing Date
2012-08-16
Accepted
2012-08-16 10:01:44
Documents
2
Group Members
CLAL INDUSTRIES & INVESTMENTS LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D zk1211886.htm SC 13D 138459
2 EXHIBIT 1 exhibit_1.htm EX-99 5788
  Complete submission text file 0001178913-12-002335.txt   145776
Mailing Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023
Business Address 3AZRIELI CENTER TRIANGLE TOWER 45 FLOOR TEL AVIV L3 67023 972-3-6075794
Clal Biotechnology Industries Ltd. (Filed by) CIK: 0001468950 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 8 HARTOM ST., 3RD FLOOR, JERUSALEM L3 97775
Business Address 8 HARTOM ST., 3RD FLOOR, JERUSALEM L3 97775 972-2-5486555
BioCancell Ltd. (Subject) CIK: 0001534248 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1211
Type: SC 13D | Act: 34 | File No.: 005-86953 | Film No.: 121038950
SIC: 2834 Pharmaceutical Preparations